Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5751 - 5775 of 6570 in total
BB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.
Investigational
Investigational
RGG0853 is an E1A lipid complex, a repressor gene complexed with a cationic lipid vector.
Investigational
Bexicaserin is under investigation in clinical trial NCT05626634 (Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy).
Investigational
Investigational
Lisaftoclax is a novel, orally active, selective and potent BCL-2 inhibitor
Investigational
Angelica sinensis root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Vonlerolizumab is under investigation in clinical trial NCT03029832 (A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-based Therapy).
Investigational
Displaying drugs 5751 - 5775 of 6570 in total